$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Daily Dividend Report: Salesforce, Brady, META, Abbvie, UTZ Brands
09:04pm, Friday, 06'th Sep 2024
Salesforce today announced that its board of directors declared a quarterly cash dividend of $0.40 per share. The dividend is payable October 8, 2024, to stockholders of record on September 18, 2024.
AbbVie Declares Quarterly Dividend
10:13am, Friday, 06'th Sep 2024
NORTH CHICAGO, Ill. , Sept. 6, 2024 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share.
Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie
04:00am, Friday, 06'th Sep 2024
Pharmaceutical (PPH) stocks have done relatively well this year. The closely watched iShares US Pharmaceutical ETF (IHE) stock has jumped by 16.5%, slightly beating the S&P 500 index, which has risen
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
04:50am, Thursday, 05'th Sep 2024
Hims & Hers is rapidly picking up steam in the telehealth industry. UnitedHealth's dominance has created massive wealth for long-term investors.
AbbVie Stock Up Almost 20% in 3 Months: Buy, Sell or Hold?
11:36am, Wednesday, 04'th Sep 2024
Investors who own ABBV stock may stay invested as the company has faced its biggest challenge, Humira's patent cliff, quite well and looks set to return to robust growth next year.
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
09:25am, Wednesday, 04'th Sep 2024
AbbVie NYSE: ABBV is a global biopharmaceutical company long synonymous with its blockbuster drug, Humira. While the drug's success has propelled AbbVie to great heights, its recent patent expiration
What's Behind The 2x Jump In AbbVie Stock?
08:00am, Tuesday, 03'rd Sep 2024
AbbVie stock (NYSE: ABBV) has more than doubled in value since early January 2021 - jumping from levels of $90 then to around $195 now - vs. an increase of about 50% for the S&P 500 over this period.
2 Dividend Stocks You Can Safely Hold Through a Recession
08:45am, Monday, 02'nd Sep 2024
These two companies sell products that remain in high demand even during recessions. They also have excellent dividend track records -- and one of them is a Dividend King.
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
05:53am, Sunday, 01'st Sep 2024
Historically, September is a relatively bad month for stock markets. AT&T offers a huge dividend yield and it could start raising the payout again next year.
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
09:45am, Friday, 30'th Aug 2024
Consumers are still spending money on healthcare and fast-casual dining. AbbVie is a faithful dividend payer with a blockbuster portfolio.
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
06:45am, Friday, 30'th Aug 2024
Abbott Labs produces medications as just one of its revenue sources. AbbVie has shown a knack for expanding the markets of its drugs.
2 Incredibly Cheap Healthcare Stocks to Buy Now
04:20am, Friday, 30'th Aug 2024
Both of these stocks have something to offer income-seeking investors. AbbVie is moving on from the loss of patent exclusivity for the world's top-selling drug.
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 29'th Aug 2024
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AbbVie Already Has The Next Humira
10:00am, Thursday, 29'th Aug 2024
AbbVie delivered Y/Y growth in the second quarter despite Humira's decline, with Skyrizi and Rinvoq as key growth drivers, achieving 45% and 56% Y/Y growth, respectively. I expect Skyrizi to become a
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
05:50am, Thursday, 29'th Aug 2024
AbbVie is a Dividend King that has proven it can successfully navigate challenges. Lowe's Companies is a great stock to own over the long run because homes will always need to be fixed up.
Sign In
Buy ABBV